1. Home
  2. SPOK vs CVRX Comparison

SPOK vs CVRX Comparison

Compare SPOK & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

SELL

Current Price

$11.11

Market Cap

230.7M

ML Signal

SELL

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$7.03

Market Cap

237.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
CVRX
Founded
2004
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.7M
237.1M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
SPOK
CVRX
Price
$11.11
$7.03
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$14.00
$10.50
AVG Volume (30 Days)
132.3K
248.6K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
10.90%
N/A
EPS Growth
2.74
23.02
EPS
0.75
N/A
Revenue
$139,708,000.00
$56,651,000.00
Revenue This Year
$1.70
$17.17
Revenue Next Year
N/A
$17.69
P/E Ratio
$15.27
N/A
Revenue Growth
1.49
10.45
52 Week Low
$10.81
$4.37
52 Week High
$19.31
$11.30

Technical Indicators

Market Signals
Indicator
SPOK
CVRX
Relative Strength Index (RSI) 42.12 38.92
Support Level $10.87 $6.74
Resistance Level $11.56 $8.93
Average True Range (ATR) 0.23 0.57
MACD 0.05 -0.06
Stochastic Oscillator 26.85 20.44

Price Performance

Historical Comparison
SPOK
CVRX

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: